This inventor holds 1 USPTO granted patent and 11 published patent applications. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: The Innovations of Carl P Sparrow
Introduction
Carl P Sparrow is an accomplished inventor based in Westfield, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic agents targeting PCSK9.
Latest Patents
Sparrow holds a patent for "Antagonists of PCSK9." This invention discloses antagonists of human proprotein convertase subtilisin-kexin type 9 (PCSK9), which are effective in inhibiting PCSK9 function. The patent outlines the use of these antagonists in treating conditions associated with PCSK9 activity. Additionally, it includes nucleic acid encoding the antagonists, vectors, host cells, and compositions comprising the antagonists. The methods for creating PCSK9-specific antagonists and their applications for inhibiting or antagonizing PCSK9 function are also detailed in the patent.
Career Highlights
Sparrow is currently associated with Merck Sharp & Dohme Corporation, where he continues to innovate in the field of pharmaceuticals. His work has contributed to advancements in treatments for various health conditions.
Collaborations
Some of his notable coworkers include Ayesha Sitlani and Shilpa Pandit, who have collaborated with him on various projects within the company.
Conclusion
Carl P Sparrow's contributions to the field of biotechnology, particularly through his patent on PCSK9 antagonists, highlight his role as a significant inventor in the industry. His work continues to pave the way for innovative treatments in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile